Pharmacologic elevation of cyclic AMP (cAMP) promotes growth arrest and differentiation in a variety of transformed mammalian cells, including the HL-60 human promyelocytic leukemia cell line. However, mechanisms underlying this phenomenon are poorly understood. Because cellular oncogenes play a pivotal role in regulating proliferation and differentiation, we examined whether cAMP-promoted differentiation of HL-60 was preceded by a decrease in the expression of c-myc, a cellular oncogene both amplified and constituitively expressed in HL-60. We find that cyclic AMP elevation in HL-60 caused by three different pharmacologic regimens is followed by an abrupt, > 90% decrease in steady state c-myc mRNA levels within 3 h, well before detectable changes in proliferation and differentiation. This decrease, which occurs despite protein synthetic blockade, is attributable to transcriptional down-regulation of c-myc and is a nied by changes in chromatin structure near c-myc promoter sites. Our findings establish that cAMP, a ubiquitous intracellular regulatory messenger previously known only to enhance gene transcriptional activity in higher eukaryotic cells, can also suppress transcription of a cellular oncogene, thereby suggesting a potential mechanism for cAMP-promoted differentiation.
Introduction
Intracellular elevation ofthe nucleotide cyclic adenosine monophosphate (cAMP), in addition to regulating specific metabolic pathways, elicits such complex changes as growth arrest and differentiation in some transformed mammalian cells-an oftendescribed (I1-6) but poorly understood phenomenon (7) . Among the cell types which undergo cAMP-promoted differentiation is HL-60 (8, 9), a human promyelocytic leukemia cell line (10) that also differentiates along either monocytic or neutrophilic lines when exposed to such chemically diverse agents as dimethylsulfoxide (DMSO) (1 1), retinoic acid (12) , or vitamin D3 (13) . Consequently, HL-60 is extensively used as a model for studying normal and leukemic hematopoietic differentiation.
Of particular interest is the attenuated expression of c-myc, a cellular oncogene amplified 10-to 20-fold in HL-60 (14) , that accompanies terminal differentiation caused by these three agents (15, 16) , which suggests a potential role for continuous expression ofc-myc in maintaining a transformed phenotype and preventing maturation. We therefore used HL-60 as a well-characterized model in which to examine the possible involvement of altered cellular oncogene expression in cAMP-promoted differentiation. We find that a surprisingly rapid and abrupt decrease in steady state c-myc messenger RNA (mRNA) levels, caused by transcriptional down-regulation and accompanied by c-myc chromatin structural changes, precedes cAMP-promoted growth arrest and differentiation in HL-60.
Methods
Materials, cell lines, and probes. Dibutyryl cAMP (dibcAMP)', cholera toxin (CT), isobutylmethylxanthine (IBMX), and actinomycin D were obtained from Sigma Chemical Co. (St. Louis, MO). The source of Bordetella adenylate cyclase toxin (BACT) was a dialyzed 4-M urea extract of intact phase I Bordetella pertussis organisms prepared as previously described (17) . HL-60 was obtained from the American Tissue Culture Collection (Rockville, MD) and adapted to grow in Iscove's tissue culture medium that contained 100 U/ml penicillin and 100 #g/mI streptomycin with 15% heat-inactivated fetal calf serum. The human c-myc probe was a 1.6-kb Sst I restriction fragment encompassing the entire first coding exon (see Fig. 4) ; the f-actin probe was a 0.7-kb Bam HI-Eco RI fragment containing a 3' untranslated portion of f-actin (18) ; and the human thymidine kinase probe was pTKI 1 (19) .
RNA extraction, dot-blot and northern hybridization. For dot-blot hybridization, total cytoplasmic RNA was extracted (20) from 106 cell aliquots of HL-60, transferred onto nitrocellulose (20) , and hybridized with nick-translated probes (1-2 X 108 cpm/Mug) (20, 21) . Hybridization conditions were 420C in 5 X standard saline citrate (SSC) and 50% formamide for 18 h; washing conditions were 650C in 0.1% sodium dodecyl sulfate (SDS), 0.1 X SSC for 1 h. Audioradiograms were prepared using Kodak XAR film and Kodak Lightening-Plus screens at -70'C for various times. For northern blot hybridization studies, RNA was extracted from 1 X 107 cells using the guanidinium isothiocyanate technique (22), polyadenylated RNA selected on oligothymidylic acid-cellulose affinity columns (23) and 5 tg electrophoresed in a 1% agarose-formaldehyde gel, transferred to nitrocellulose (24) , and probed as described above.
In vitro nuclear run-offtranscription assay. Nuclei from 5 X I0' HL-60 cells were incubated in the presence of [32PJUTP (25) , labeled RNA isolated, and 2 X 106 cpm hybridized to filters (25) to which 5 ,gg of the indicated plasmid DNA had previously been bound (26 Corp., Freehold, NJ) concentrations from 0 to 10 U/mI, and incubated 10 min at 37°C (27). Digestion was stopped by the addition of 1% SDS and 20 mM EDTA. Each sample was then digested with 1 mg/ml proteinase K at 37°C overnight. DNA was isolated by repeated organic extractions and ethanol precipitation. Samples were then digested to completion with Bgl II, and 10 gg was electrophoresed on a 0.8% agarose gel (27). A graded series of four digestions from each treatment group, chosen by ethidium bromide staining to reflect comparable extents of overall DNA degradation among the three groups, was re-electrophoresed on 0.8% agarose, hybridized (27) with the 1.6-kb c-myc probe previously described, and autoradiograms made.
Results
In preparatory experiments (not shown) we first defined the time course of the cAMP effect upon HL-60 proliferation. Because pharmacologic agents that elevate cAMP may have unrelated, ,uM dibcAMP, a lipophilic analogue of cAMP that crosses cell membranes; (b) 25 ng/ml CT, a stimulant of membrane-bound adenylate cyclase with 500 gM IBMX, which is a cAMP phosphodiesterase inhibitor; and (c) 150 Mg protein/ml of a crude bacterial extract containing BACT. This last agent, produced by B. pertussis, is a membrane-invasive adenylate cyclase (17) that penetrates a variety of mammalian cells (28) , including HL-60 (9), and generates large intracellular accumulations ofauthentic cAMP from intracellular ATP stores. The three regimens affected HL-60 proliferation identically: pulse [3H]thymidine incorporation into TCA-precipitable material was minimally affected through 6 h, but declined to 50% that of untreated cells by 12 h, 20% by 24 h, and < 3% from days 2 through 5. The similar effects ofthree cAMP induction regimens demonstrate a cAMPspecific effect upon HL-60 proliferation.
To determine levels of c-myc mRNA during cAMP-dependent HL-60 differentiation we performed quantitative dot-blot hybridization oftotal cytoplasmic RNA. In response to the three cAMP induction regimens described above, c-myc RNA levels decline abruptly by 3 h and remain < 10% that of control throughout the assay period of 3 d (Fig. 1 A) . The cAMP effect on c-myc expression is not simply due to generalized RNA degradation because steady state levels of ,B-actin are unaffected (Fig. 1 B) . The decrease in total cytoplasmic c-myc RNA detected in the dot-blot assay reflects polyadenylated RNA levels (Fig. 1  C) . This cAMP-dependent decrement in c-myc RNA levels does not depend upon ongoing protein synthesis (and, by implication, altered translational expression ofother genes) because it occurs p-actn RNA isolated, and 2 X 106 cpm hybridized to filters to which 5 Mg of the indicated plasmid DNA had previously been bound and autoradiograms made. Columns designated pSV2neo and pUC18 are vector controls containing no insert; c-myc and fl-actin are these intact plasmids containing, respectively, the c-myc and fl-actin clones described in Fig. 1 . hu-TK is a plasmid containing a complementary DNA clone of human thymidine kinase, pTKl 1. despite the presence of 2 Jg/ml cycloheximide, which blocks > 90% of [3H]leucine incorporation into HL-60 cells (Fig. 1 A) .
Cells treated with BACT plus cycloheximide had decreased viability by day 1, so data beyond 5 h are not shown; cycloheximide alone induced c-myc levels.
c-myc RNA levels are regulated either at the level of transcription (29) or by modulation ofc-myc RNA degradation (30) , which is normally very rapid (half-life of 10 min) (31) . To assess the former possibility, we used an in vitro nuclear runoff assay that detects the presence of active polymerases along a specific gene (25) min (Fig. 3) . Developmental activation of gene transcription is accompanied by changes in chromatin structure. These are detectable both as an overall increase in DNase sensitivity ofDNA in coding regions (32) and as localized DNase hypersensitive sites near the 5' end of the coding region and on regulatory sequences (33) .
To determine whether such chromatin structural changes also accompany cAMP-dependent transcriptional down-regulation of c-myc, we compared DNase I hypersensitive site patterns of c-myc at three stages during cAMP-promoted differentiation of HL-60. By 4 h, when c-myc transcription was first found to be attenuated, dibcAMP-treated cells demonstrated a relative resistance of c-myc DNA to DNase I digestion when compared with that ofuntreated cells (Fig. 4) . By day 2, after growth arrest and differentiation had occurred, the intensities of hypersensitive sites II and III were markedly decreased relative to those of hypersensitive sites I and V (Fig. 4) . Similar changes in c-myc hypersensitive site patterns were seen in cells treated with CT and IBMX (not shown).
Discussion
The c-myc gene encodes a nuclear phosphoprotein that may function as a cell cycle-specific "competence factor" permitting traversal of the GI phase ofthe cell cycle (34) . c-myc is constituitively expressed in a variety of transformed cells, including HL-60 (14) , and transiently expressed during normal hematopoietic differentiation of human granulocyte precursors (35) . Moreover, c-myc expression is attenuated in HL-60 cells terminally differentiated with retinoic acid (15) , DMSO (15) , and vitamin D3 (16), suggesting a potential role for continuous c-myc expression in maintaining a transformed phenotype. However, the growth inhibition, differentiation, and decline in c-myc expression that follows treatment with these agents all occur gradually over several days (29, 36) , and therefore do not exclude the possibility that decreased c-myc expression is simply a consequence, not a cause, of growth arrest and differentiation. In contrast, cAMP causes growth arrest and differentiation of HL-60 within 24 h (8, 9). Our finding that a rapid transcriptional down-regulation of c-myc precedes these cAMP-specific effects supports a per- Investigating the mechanism behind rapid extinction of c-myc expression in HL-60 after cAMP elevation, we found a transcriptional down-regulation accompanied by diminished expression of DNase I hypersensitive II sites and III (29, 38) . These sites are located just upstream of, respectively, promoter sequences previously designated as PO (29) or PI and P2 (39) .
Moreover, preliminary experiments utilizing exon-specific probes indicate that down-regulation of c-myc is caused by a block to transcriptional elongation between exons I and II (unpublished observations). Strikingly similar changes accompany HL-60 differentiation caused by DMSO (38, 40) and retinoic acid (29) , but occur much more slowly-over days rather than within 4 h. In view of these mechanistic similarities, the relative speed with which cAMP attenuates c-myc transcriptional activity suggests that DMSO and retinoic acid-structurally unrelated substances with no known role in the regulation of normal cellular functions-might ultimately act through a mechanism dependent upon cAMP, an endogenous intracellular signalling substance. The observation that retinoic acid, DMSO, and phorbol esters also increase nucleosol-associated cAMP-dependent protein kinase activity in HL-60 (41) supports this hypothesis.
The role of cAMP in regulating such cytosolic metabolic pathways as glycogenolysis is well characterized. In contrast, understanding of mechanisms underlying such complex phenomena as cAMP-dependent growth arrest and differentiation, which likely involve changes in gene expression, remains rudimentary (7). Though cAMP alters gene expression in mammalian cells (42) , previous investigations have only shown cAMP capable of stimulating transcriptional activity of differentiation-specific genes, such as prolactin and growth hormone in rat pituitary cells (43) . We demonstrate a rapid, cAMP-specific decrement in HL-60 c-myc RNA levels mediated by transcriptional downregulation-to our knowledge the first example ofthis phenomenon in higher eukaryotic cells. The detection of concomitant c-myc chromatin structural changes further emphasizes that cAMP attenuation of c-myc is effected at the genomic level. Thus, our studies extend previous correlations between exposure to cAMP analogues and decreases in steady state levels of oncogene protein (44) and RNA (45) , and raise the possibility that transcriptional modulation of oncogene expression may, in part, mediate cAMP-dependent differentiation in other transformed cell types. One hypothetical mechanism envisions cAMP simultaneously promoting transcription ofgenes encoding proteins characteristic of terminal differentiation, while repressing transcription ofgenes, such as c-myc, which may permit continuous proliferation and block differentiation.
Our findings in HL-60 leukemic cells may also have relevance to normal hematopoiesis. Several agents that increase intracellular cAMP, including monocyte-derived prostaglandins of the E series (PGEs), inhibit proliferation of colony-forming units of granulocyte-.macrophage precursors (CFU-GM) in a soft agar cloning assay (46, 47) . Monocytes and macrophages have on this basis been implicated as participating in intrinsic negative feedback control of normal myelopoiesis (47) . Human bone Cyclic Adenosine Monophosphate and c-myc 1545 Bgl r marrow cells exposed to growth factors that promote CFU-GM growth transiently, but strongly express c-myc 24 h later, when cells morphologically identifiable as promyelocytes predominate (35) . cAMP-promoted transcriptional down-regulation of c-myc, were it to occur in normal as well as HL-60 leukemic promyelocytes, could mediate suppression of CFU-GM growth in response to cAMP elevation. Thus, cAMP, which is generated by a receptor-coupled adenylate cyclase complex, may prove to serve as an important second messenger intermediary between extracellular signals and nuclear regulation of oncogene expression.
